Screening of cognitive impairment in patients with Parkinson's disease: diagnostic validity of the Brazilian versions of the Montreal Cognitive Assessment and the Addenbrooke's Cognitive Examination-Revised

Article English OPEN
Emmanuelle Sobreira; Márcio A. Pena-Pereira; Alan L. Eckeli; Manoel A. Sobreira-Neto; Marcos H. N. Chagas; Maria P. Foss; Brenna Cholerton; Cyrus P. Zabetian; Ignacio F. Mata; Vitor Tumas;
(2015)
  • Publisher: Academia Brasileira de Neurologia - ABNEURO
  • Journal: issn: 1678-4227
  • Publisher copyright policies & self-archiving
  • Related identifiers: doi: 10.1590/0004-282X20150156
  • Subject: COMPROMETIMENTO COGNITIVO LEVE | Neurosciences. Biological psychiatry. Neuropsychiatry | DOENÇA DE PARKINSON | testes neuropsicológicos | RC321-571 | cognitive assessment | DEMÊNCIA | ACE-R | APTIDÃO COGNITIVA (AVALIAÇÃO) | MoCA | avaliação cognitiva | dementia | mild cognitive impairment | neuropsychological tests | Parkinson's disease
    mesheuropmc: mental disorders | nervous system diseases

ABSTRACTObjective The aim of the present study is to examine the accuracy of the Brazilian versions of the Montreal Cognitive Assessment (MoCA) and the Addenbrooke's Cognitive Examination-Revised (ACE-R) to screen for mild cognitive impairment (PDMCI) and dementia (PDD)... View more